BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25383461)

  • 1. Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene.
    Sonobe S; Fujimura M; Niizuma K; Fujimura T; Furudate S; Nishijima Y; Kure S; Tominaga T
    Neuroreport; 2014 Dec; 25(18):1442-6. PubMed ID: 25383461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease.
    Sonobe S; Fujimura M; Niizuma K; Nishijima Y; Ito A; Shimizu H; Kikuchi A; Arai-Ichinoi N; Kure S; Tominaga T
    Brain Res; 2014 Mar; 1552():64-71. PubMed ID: 24440776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease.
    Kanoke A; Fujimura M; Niizuma K; Ito A; Sakata H; Sato-Maeda M; Morita-Fujimura Y; Kure S; Tominaga T
    Brain Res; 2015 Oct; 1624():497-505. PubMed ID: 26315378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease.
    Ito A; Fujimura M; Niizuma K; Kanoke A; Sakata H; Morita-Fujimura Y; Kikuchi A; Kure S; Tominaga T
    Brain Res; 2015 Jan; 1594():310-20. PubMed ID: 25446450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease.
    Kanoke A; Fujimura M; Niizuma K; Fujimura T; Kakizaki A; Ito A; Sakata H; Sato-Maeda M; Kure S; Tominaga T
    Brain Res; 2016 Jul; 1642():1-9. PubMed ID: 26972532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient middle cerebral artery occlusion in mice induces neuronal expression of RNF213, a susceptibility gene for moyamoya disease.
    Sato-Maeda M; Fujimura M; Kanoke A; Morita-Fujimura Y; Niizuma K; Tominaga T
    Brain Res; 2016 Jan; 1630():50-5. PubMed ID: 26556774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo.
    Kobayashi H; Matsuda Y; Hitomi T; Okuda H; Shioi H; Matsuda T; Imai H; Sone M; Taura D; Harada KH; Habu T; Takagi Y; Miyamoto S; Koizumi A
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26126547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown the moyamoya disease susceptibility gene, RNF213, upregulates the expression of basic fibroblast growth factor and matrix metalloproteinase-9 in bone marrow derived mesenchymal stem cells.
    Li Z; Liu Y; Li X; Yang S; Feng S; Li G; Jin F; Nie S
    Neurosurg Rev; 2024 May; 47(1):246. PubMed ID: 38811382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of
    Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T
    Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells.
    Ohkubo K; Sakai Y; Inoue H; Akamine S; Ishizaki Y; Matsushita Y; Sanefuji M; Torisu H; Ihara K; Sardiello M; Hara T
    Sci Rep; 2015 Aug; 5():13191. PubMed ID: 26278786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new horizon of moyamoya disease and associated health risks explored through RNF213.
    Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
    Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans.
    Park MG; Shin JH; Lee SW; Park HR; Park KP
    J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
    Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease.
    Miyatake S; Miyake N; Touho H; Nishimura-Tadaki A; Kondo Y; Okada I; Tsurusaki Y; Doi H; Sakai H; Saitsu H; Shimojima K; Yamamoto T; Higurashi M; Kawahara N; Kawauchi H; Nagasaka K; Okamoto N; Mori T; Koyano S; Kuroiwa Y; Taguri M; Morita S; Matsubara Y; Kure S; Matsumoto N
    Neurology; 2012 Mar; 78(11):803-10. PubMed ID: 22377813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of Moyamoya disease in Han Chinese human subjects.
    Wang X; Zhang Z; Liu W; Xiong Y; Sun W; Huang X; Jiang Y; Ni G; Sun W; Zhou L; Wu L; Zhu W; Li H; Liu X; Xu G
    Gene; 2013 Sep; 526(2):437-42. PubMed ID: 23769926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease.
    Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
    Liao X; Deng J; Dai W; Zhang T; Yan J
    Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Precision Medicine for Moyamoya Disease].
    Fujimura M
    No Shinkei Geka; 2022 Jan; 50(1):216-221. PubMed ID: 35169101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of Rnf213 retards progression of diabetes in the Akita mouse.
    Kobayashi H; Yamazaki S; Takashima S; Liu W; Okuda H; Yan J; Fujii Y; Hitomi T; Harada KH; Habu T; Koizumi A
    Biochem Biophys Res Commun; 2013 Mar; 432(3):519-25. PubMed ID: 23410753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.